By Fineline Cube 
Guangzhou-based Ayshealth Technology, a developer of tissue repair and reconstruction devices, has reportedly secured an undisclosed amount of funding in an angel financing round led by Dalton Venture. The proceeds will be allocated to advancing the clinical study of its small-caliber artificial blood vessel and expanding the application and development of its core technology.
Commitment to Innovation
Founded in 2023, Ayshealth Technology is dedicated to the research, development, manufacturing, and sales of high-end implantable medical devices. This recent funding underscores the company’s commitment to innovation and its mission to address unmet medical needs in the field of tissue repair and reconstruction.
Future Development
With the support from Dalton Venture, Ayshealth is poised to accelerate its research and development efforts, particularly in the area of artificial blood vessels. The company’s focus on advancing clinical studies and expanding its technological applications reflects its strategic vision to become a leader in the medical device industry.-Fineline Info & Tech